The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

16 Jan 2017 07:00

RNS Number : 1851U
InnovaDerma PLC
16 January 2017
 

InnovaDerma PLC

("InnovaDerma", the "Group" or the "Company")

Trading Update

InnovaDerma (LON: IDP), a UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, today provides its trading update for the six months ended 31 December 2016.

 

Trading Performance

The Board is pleased to announce that the Group's first half year financial performance has been encouraging and revenues are expected to show growth of just over 80% year-on-year on a constant currency basis to approximately £3.0 million (unaudited). The increase in revenue has been driven by the Company's expansion strategy in the UK with the strong performance of Skinny Tan, a premium self-tanner brand that combines a natural tanning active, to tan and reduce the visible appearance of cellulite, which was launched in February 2016 through Superdrug. As set out in the Full Year results, the Group's strategies are to extend the Skinny Tan brand to build customer loyalty, and use a digital direct to consumer strategy to drive sales. Both have contributed positively to revenue growth.

 

The Group has undertaken significant corporate activity in the first half including listing on the Main Market of the London Stock Exchange, opening up the US market, and the transition of its manufacturing to the UK. One off costs associated with these activities will be absorbed into the first half of the financial year. As previously indicated by the Board in its operational update and entry into the American market on 24 October and 31 October 2016 respectively, it believes that these strategic initiatives will drive top line revenue and earnings from the second half of the Company's financial year.

 

The Board is pleased with the progress of the Company and looks forward to discussing this further at the time of its interim results expected to be in February.

 

The Company considers this announcement to contain inside information which is disclosed in accordance with the Market Abuse Regulation.

 

Further enquiries

InnovaDerma

Haris Chaudhry/Joe Bayer

 

 

+61 (0)3 9111 0071

Sole broker

Hybridan LLP

Claire Noyce

 

+44 (0)203 764 2341

Cardew Group

Shan Shan Willenbrock

David Roach

Emma Ruttle

 

+ 44 (0)20 7930 0777

 

About InnovaDerma:

InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

www.innovaderma.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKNDQOBKDQDD
Date   Source Headline
15th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSFinal Results
28th Sep 20207:00 amRNSUS distributor appointed and Nuthing launch in AUS
18th Sep 20207:00 amRNSNotice of Results and Presentation
1st Sep 20209:37 amRNSHolding(s) in Company
12th Aug 202010:58 amRNSHolding(s) in Company
5th Aug 20209:15 amRNSDirectorate Change
31st Jul 202010:22 amRNSHolding(s) in Company
13th Jul 20209:40 amRNSHolding(s) in Company
10th Jul 20207:00 amRNSTrading Statement
1st Jul 202010:10 amRNSHolding(s) in Company
12th Jun 20205:57 pmRNSHolding(s) in Company
26th May 20207:00 amRNSTrading Statement
13th May 20204:42 pmRNSHolding(s) in Company
7th May 202010:52 amRNSDirector/PDMR Shareholding
6th May 202010:05 amRNSHolding(s) in Company
4th May 202011:09 amRNSHolding(s) in Company
30th Apr 202011:05 amRNSSecond Price Monitoring Extn
30th Apr 202011:00 amRNSPrice Monitoring Extension
6th Apr 20202:05 pmRNSSecond Price Monitoring Extn
6th Apr 20202:00 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSCOVID-19 Update
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
18th Mar 20201:56 pmRNSDirector/PDMR Shareholding
17th Mar 20201:52 pmRNSHolding(s) in Company
16th Mar 202012:54 pmRNSDirector/PDMR Shareholding
12th Mar 20202:37 pmRNSDirector/PDMR Shareholding
12th Mar 202011:06 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
3rd Mar 202010:47 amRNSDirector/PDMR Shareholding
25th Feb 202011:52 amRNSHalf-year Report- Replacement
25th Feb 20207:00 amRNSHalf-year Report
24th Feb 20207:00 amRNSInnovaDerma launches new brand "Nuthing"
3rd Feb 20207:00 amRNSNotice of Results
23rd Jan 20208:48 amRNSGrant of Options/PDMR Dealing
9th Jan 20207:00 amRNSTrading Statement
5th Dec 20197:00 amRNSDTC channel delivers best Black Friday weekend
29th Nov 20192:26 pmRNSDirector/PDMR Shareholding
28th Nov 20193:21 pmRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSLaunch of new Skinny Tan 'Choc' range in Superdrug
13th Nov 201912:39 pmRNSDirector/PDMR Shareholding
8th Nov 20193:40 pmRNSDirector/PDMR Shareholding
8th Nov 20193:22 pmRNSDirector/PDMR Shareholding
7th Nov 20192:33 pmRNSHolding(s) in Company
7th Nov 20191:55 pmRNSHolding(s) in Company
7th Nov 20191:53 pmRNSDirector/PDMR Shareholding
7th Nov 20191:47 pmRNSDirectorate Change
6th Nov 201911:01 amRNSResult of AGM
6th Nov 20197:00 amRNSAGM Statement
31st Oct 20197:00 amRNSLaunch of new category in Superdrug

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.